Your browser doesn't support javascript.
loading
LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial.
Hasenburg, Annette; Sehouli, Jalid; Lampe, Bjoern; Reuss, Alexander; Schmalfeld, Barbara; Belau, Antje Kristina; Bossart, Michaela; Mahner, Sven; Hillemanns, Peter; Petry, Ulrich; du Bois, Andreas; Herwig, Uwe; Hilpert, Felix; Gropp-Meier, Martina; Hanf, Volker; Greimel, Elfriede; Wagner, Uwe; Harter, Philipp.
Affiliation
  • Hasenburg A; Department of Obstetrics and Gynecology, University Medical Center, Mainz, Germany Annette.Hasenburg@unimedizin-mainz.de.
  • Sehouli J; Department of Gynecology with Center for Oncological Surgery, Campus Virchow Klinikum, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, New Hampshire, USA.
  • Lampe B; Department of Gynecology and Obstetrics, Kaiserswerther Diakonie, Duesseldorf, Germany.
  • Reuss A; Coordinating Centre for Clinical Trials, Philipps-Universität Marburg, Marburg, Germany.
  • Schmalfeld B; Department of Gynecology and Obstetrics, University Hospital Ludwig-Maximilians-University Munich, München, Bayern, Germany.
  • Belau AK; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bossart M; Department of Gynecology and Obstetrics, University of Greifswald, Greifswald, Germany.
  • Mahner S; Department of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg, Germany.
  • Hillemanns P; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Petry U; Department of Gynecology and Obstetrics, University Hospital, LMU Munich, München, Germany.
  • du Bois A; Department of Gynecology and Obstetrics, Medizinische Hochschule, Hannover, Germany.
  • Herwig U; Department of Gynecology and Obstetrics, Klinikum Wolfsburg, Wolfsburg, Niedersachsen, Germany.
  • Hilpert F; Department of Gynecology and Gynecological Oncology, KEM, Kliniken Essen Mitte, Essen, Germany.
  • Gropp-Meier M; Department of Gynecology and Obstetrics, Albertinen-Hospital Hamburg, Hamburg, Germany.
  • Hanf V; Department of Gynecology and Obstetrics, Universitätsklinikum Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Greimel E; Mammazentrum Hamburg, Krankenhaus Jerusalem, Hamburg, Germany.
  • Wagner U; Department of Gynecology and Obstetrics, St. Elisabethenhospital, Ravensburg, Baden-Württemberg, Germany.
  • Harter P; Department of Gynecology and Obstetrics, Klinikum Fürth, Fürth, Bayern, Germany.
Int J Gynecol Cancer ; 30(10): 1548-1553, 2020 10.
Article in En | MEDLINE | ID: mdl-32938723
BACKGROUND: There is limited information about the impact of radical surgery including pelvic and para-aortic lymphadenectomy and subsequent platinum-based chemotherapy on sexuality in patients with advanced ovarian cancer. OBJECTIVE: To evaluate the impact of radical surgery including pelvic and para-aortic lymphadenectomy and subsequent platinum-based chemotherapy on sexuality in patients with advanced ovarian cancer as a sub-protocol of the prospectively randomized LION trial. METHODS: The Sexual Activity Questionnaire was applied to assess sexual function according to its sub-scales activity, pleasure, and discomfort. The 'orgasm' sub-scale from the Female Sexual Function Index was also added. The questionnaire was administered in combination with the EORTC QLQ-C30 questionnaire at baseline prior surgery, after 6, 12, and 24 months. The primary endpoint was changes in sexual function. RESULTS: Overall, 495 patients received the questionnaires. 254 (51%) responded at baseline. Of these, 55 (22%) patients were sexually active, 182 (72%) were sexually inactive, and for 17 (7%) patients' data were not available. There was a total of 55/495 (11%) patients at 6 months, 139 (28%) patients at 12 months, and 81 (16%) patients at 24 months. Median age was 60.5 years (range 21.4-75.8). At baseline, sexually active responders were significantly younger (median age 51.5 years,) than sexually inactive responders (median age 61.8 years) and tended to have a better performance status. Discomfort evaluated as dryness of the vagina and pain during sexual intercourse was significantly worse at 12 months than at baseline (p<0.001); however, the surgical variable, lymphadenectomy, did not have any impact on this. The orgasm sub-scale showed diverging results with a deterioration from baseline to 12 months in the lymphadenectomy group compared with the no-lymphadenectomy group (p=0.02). CONCLUSION: The majority of patients were sexually inactive; however, in those who were sexually active, pain during intercourse was worse at 12 months. In addition, the orgasm sub-scale demonstrated worse results in patients who underwent complete lymphadenectomy. The study suggests that surgery in the retroperitoneal space may influence sexual function.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Dyspareunia / Lymph Node Excision Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2020 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Dyspareunia / Lymph Node Excision Type of study: Clinical_trials / Observational_studies Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Int J Gynecol Cancer Journal subject: GINECOLOGIA / NEOPLASIAS Year: 2020 Type: Article Affiliation country: Germany